LPS-induced release of IL-6 from glia modulates production of IL-1β in a JAK2-dependent manner

Type 1 TNF Receptor Forms a Complex with and Uses Jak2 and c-Src to Selectively Engage Signaling Pathways That Regulate Transcription Factor Activity

(2014) R. Pincheira et al.   JOURNAL OF IMMUNOLOGY

Inhibition of JAK2 Signaling by TG101209 Enhances Radiotherapy in Lung Cancer Models

(2011) Yunguang Sun et al.   Journal of Thoracic Oncology

TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells

(2010) Vijay Ramakrishnan et al.   AMERICAN JOURNAL OF HEMATOLOGY

JAK2 is an important signal transducer in IL-33-induced NF-κB activation

(2010) Megumi Funakoshi-Tago et al.   CELLULAR SIGNALLING

Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells

(2009) Y. Wang et al.   BLOOD

Essential involvement of cross-talk between IFN-γ and TNF-α in CXCL10 production in human THP-1 monocytes

(2009) Xu-Feng Qi et al.   JOURNAL OF CELLULAR PHYSIOLOGY